International Assets Investment Management’s VanEck Biotech ETF BBH Stock Holding History

International Assets Investment Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11	Closed	-$2.14K	–	2253
2025 Q4	$2.14K	Buy	+11	New	+$2.04K	﹤0.01%	1949
2024 Q4	–	Sell	-11,074	Closed	-$1.14M	–	916
2024 Q3	$1.14M	Buy	11,074 +11,063	+100,573%	+$1.96M	0.09%	183
2024 Q2	$1.88K	Buy	+11	New	+$1.8K	﹤0.01%	2015

Other funds holding BBH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return

International Assets Investment Management's BBH Position: Q1 2026 in Review

International Assets Investment Management sold out of VanEck Biotech ETF (BBH) in Q1 2026, closing a stake of 11 shares — an estimated $2.14K sold.

International Assets Investment Management first reported a position in BBH in Q2 2024 and held it in 3 quarters. The position peaked at $1.14M in Q3 2024. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

International Assets Investment Management reported no remaining VanEck Biotech ETF position as of Q1 2026 after selling out during the quarter.
International Assets Investment Management sold 11 VanEck Biotech ETF shares in Q1 2026, an estimated $2.14K.
International Assets Investment Management first reported a position in VanEck Biotech ETF in Q2 2024 and held it in 3 quarters.
International Assets Investment Management's VanEck Biotech ETF position peaked at $1.14M in Q3 2024.
112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on International Assets Investment Management's 13F filing for Q1 2026, filed 1 May 2026.